Drug intelligence / Profile preview

Iberet-Folic 500

Development stage
Unknown
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Iberet-Folic 500 is a multi-ingredient hematinic supplement formulated to treat and prevent iron deficiency anemia and associated nutritional deficiencies, particularly during pregnancy and the postpartum period. It contains 525 mg of ferrous sulfate (equivalent to 105 mg of elemental iron) delivered via the Gradumet controlled-release technology, which is designed to minimize gastrointestinal irritation by releasing iron slowly in the small intestine. The formulation is supplemented with 500 mg of ascorbic acid (Vitamin C) to enhance the absorption of iron, 800 mcg of folic acid to support erythropoiesis and prevent neural tube defects, and a comprehensive B-complex (B1, B2, B3, B5, B6, B12) to support cellular metabolism. In the context of clinical research at the University of Malaya, it is utilized as a standard oral iron therapy for correcting hemoglobin deficits and replenishing iron stores in women with postpartum anemia following hemorrhage.

Brand names
Iberet-FolicIberet-Folic 500Iberet-Folic500Iberet-Folic-500
Other names
Ferrous sulfate + Folic acid + Vitamin C + B-complex
02

Targets

SLC11A2 (DMT1)SLC46A1 (Proton-coupled folate transporter)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Iberet-Folic 500.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iberet-Folic 500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call